Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -69.27% is 40% below its 5-year average of -49.33%, around the middle of its 5-year range (-308.98%–43.19%).
20.98% above its 12-month average of -87.66%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -118.50%.
NET PROFIT MARGIN
-69.27%
NET PROFIT MARGIN AVG TTM
-87.66%
NET PROFIT MARGIN AVG 3Y
-61.96%
NET PROFIT MARGIN AVG 5Y
-49.33%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+20.98%
CURRENT VS 3Y AVG
-11.79%
CURRENT VS 5Y AVG
-40.42%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-26542.31%
vs the sector median at left
Spectral AI, Inc.
Market Cap
$52.83M
Net Profit Margin
-69.27%
TTM Avg
-87.66%
3Y Avg
-61.96%
5Y Avg
-49.33%
Market Cap
$52.60M
Net Profit Margin
-59.97%
TTM Avg
-26.95%
3Y Avg
-5.27%
5Y Avg
-0.58%
Market Cap
$51.99M
Net Profit Margin
N/A
TTM Avg
-24.71%
3Y Avg
-12.36%
5Y Avg
-8.24%
Market Cap
$53.70M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$51.88M
Net Profit Margin
-5668.62%
TTM Avg
-3356.71%
3Y Avg
-1974.47%
5Y Avg
-1414.89%
Market Cap
$54.14M
Net Profit Margin
-618.02%
TTM Avg
-2368.57%
3Y Avg
-1184.28%
5Y Avg
-1443.19%
Market Cap
$51.19M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$51.12M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Spectral AI, Inc. (MDAI) | $52.83M | -69.27% | -87.66% | -61.96% | -49.33% |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | -59.97% | -26.95% | -5.27% | -0.58% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.99M | N/A | -24.71% | -12.36% | -8.24% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.70M | 0.00% | 0.00% | 0.00% | 0.00% |
| ImageneBio Inc (IMA)vs › | $51.88M | -5668.62% | -3356.71% | -1974.47% | -1414.89% |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $54.14M | -618.02% | -2368.57% | -1184.28% | -1443.19% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | 0.00% | 0.00% | 0.00% | 0.00% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aldeyra The (ALDX)vs › | $55.25M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-43.8%
Net Profit Margin
-69.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -118.50% |
| 2026-03-31 | -85.49% |
| 2025-12-31 | 16.68% |
| 2025-09-30 | -93.67% |
| 2025-06-30 | -157.31% |
| 2025-03-31 | 43.19% |
| 2024-12-31 | -101.81% |
| 2024-09-30 | -18.40% |
| 2024-06-30 | -38.30% |
| 2024-03-31 | -50.66% |
| 2023-12-31 | -67.07% |
| 2023-09-30 | -308.98% |
| 2023-06-30 | -72.22% |
| 2023-03-31 | -71.07% |
| 2022-12-31 | -28.53% |
| 2022-09-30 | -5.40% |
| 2022-06-30 | -4.15% |
| 2022-03-31 | -9.03% |
| 2021-12-31 | -37.76% |
| 2021-09-30 | -37.76% |
